A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

545

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
InsomniaDepressive Disorder, Major
Interventions
DRUG

Eszopiclone

Eszopiclone 3 mg QD

OTHER

Placebo

Placebo tablet

Trial Locations (65)

Unknown

Birmingham

Peoria

Tucson

Fayetteville

Garden Grove

Irvine

Northridge

Riverside

San Diego

Wheat Ridge

New Britian

Jacksonville

Miami

Miami Beach

North Miami

St. Petersburg

Atlanta

Augusta

Decatur

Smyrna

Boise

Overland Park

Rockville

Boston

Braintree

Brighton

Brockton

Cambridge

Watertown

Farmington Hills

St Louis

Omaha

Clementon

Morestown

Lawerence

New York

The Bronx

Durham

Winston-Salem

Bismarck

Beachwood

Cincinnati

Dayton

Oklahoma City

Eugene

Portland

Salem

Springfield

Conshohocken

Emmaus

Philadelphia

Scotland

Anderson

Madison

Memphis

Selmer

Austin

San Antonio

Wichita Falls

Salt Lake City

Richmond

Lakewood

Seatle

Spokane

Madison

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT00368030 - A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder | Biotech Hunter | Biotech Hunter